Ipca Laboratories Limited (BOM: 524494)
India
· Delayed Price · Currency is INR 1,584.25
-9.20 (-0.58%)
At close: Dec 20, 2024
Ipca Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Operating Revenue | 85,334 | 77,050 | 62,443 | 58,298 | 54,200 | 46,487 | Upgrade
|
| Other Revenue | 8.4 | 8.4 | 37.9 | 7.1 | 7.4 | 11.5 | Upgrade
|
| Revenue | 85,343 | 77,059 | 62,481 | 58,305 | 54,207 | 46,499 | Upgrade
|
| Revenue Growth (YoY) | 27.75% | 23.33% | 7.16% | 7.56% | 16.58% | 23.18% | Upgrade
|
| Cost of Revenue | 30,566 | 28,475 | 25,229 | 22,080 | 18,965 | 17,877 | Upgrade
|
| Gross Profit | 54,776 | 48,584 | 37,252 | 36,225 | 35,242 | 28,621 | Upgrade
|
| Selling, General & Admin | 19,458 | 17,314 | 13,076 | 11,964 | 10,309 | 9,362 | Upgrade
|
| Other Operating Expenses | 20,803 | 18,412 | 14,537 | 11,374 | 9,720 | 9,753 | Upgrade
|
| Operating Expenses | 44,199 | 39,268 | 30,218 | 25,635 | 22,097 | 21,200 | Upgrade
|
| Operating Income | 10,578 | 9,316 | 7,034 | 10,591 | 13,146 | 7,421 | Upgrade
|
| Interest Expense | -1,084 | -1,373 | -450.9 | -72.4 | -86.1 | -158.4 | Upgrade
|
| Interest & Investment Income | 629.3 | 629.3 | 793.5 | 341.7 | 369.5 | 323 | Upgrade
|
| Earnings From Equity Investments | -27.6 | -62.9 | -129.4 | -211.6 | -77 | -78.1 | Upgrade
|
| Currency Exchange Gain (Loss) | 329.5 | 329.5 | -315.1 | 307.9 | 413 | -150.6 | Upgrade
|
| Other Non Operating Income (Expenses) | -318.4 | 46.9 | 110.1 | 70.4 | 133.1 | 183.8 | Upgrade
|
| EBT Excluding Unusual Items | 10,107 | 8,886 | 7,042 | 11,027 | 13,898 | 7,541 | Upgrade
|
| Merger & Restructuring Charges | 4.5 | -390.4 | - | - | - | - | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -158.4 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 547.1 | 547.1 | 149.7 | 232.9 | 101.4 | 60.6 | Upgrade
|
| Gain (Loss) on Sale of Assets | 6.2 | 6.2 | 160.5 | -0.3 | - | 78.1 | Upgrade
|
| Asset Writedown | 2.1 | 2.1 | -28.4 | -113.6 | -28.6 | -290.6 | Upgrade
|
| Other Unusual Items | -687.1 | -687.1 | - | - | - | - | Upgrade
|
| Pretax Income | 9,980 | 8,364 | 7,324 | 11,146 | 13,813 | 7,389 | Upgrade
|
| Income Tax Expense | 3,307 | 3,135 | 2,534 | 2,248 | 2,401 | 1,353 | Upgrade
|
| Earnings From Continuing Operations | 6,672 | 5,229 | 4,790 | 8,898 | 11,411 | 6,036 | Upgrade
|
| Minority Interest in Earnings | -60.3 | 244.3 | -76.7 | -57.1 | -11.3 | 27.6 | Upgrade
|
| Net Income | 6,612 | 5,474 | 4,713 | 8,841 | 11,400 | 6,063 | Upgrade
|
| Net Income to Common | 6,612 | 5,474 | 4,713 | 8,841 | 11,400 | 6,063 | Upgrade
|
| Net Income Growth | 34.32% | 16.13% | -46.69% | -22.45% | 88.02% | 36.30% | Upgrade
|
| Shares Outstanding (Basic) | 254 | 254 | 254 | 254 | 253 | 253 | Upgrade
|
| Shares Outstanding (Diluted) | 254 | 254 | 254 | 254 | 253 | 253 | Upgrade
|
| Shares Change (YoY) | 0.05% | - | - | 0.17% | 0.16% | 0.09% | Upgrade
|
| EPS (Basic) | 26.05 | 21.57 | 18.58 | 34.85 | 45.01 | 23.99 | Upgrade
|
| EPS (Diluted) | 26.05 | 21.57 | 18.58 | 34.85 | 45.01 | 23.98 | Upgrade
|
| EPS Growth | 34.26% | 16.13% | -46.69% | -22.58% | 87.73% | 36.18% | Upgrade
|
| Free Cash Flow | 8,977 | 5,341 | 3,113 | 3,771 | 7,286 | 2,641 | Upgrade
|
| Free Cash Flow Per Share | 35.38 | 21.05 | 12.27 | 14.86 | 28.77 | 10.44 | Upgrade
|
| Dividend Per Share | 4.000 | 4.000 | 4.000 | 4.000 | 4.000 | 2.500 | Upgrade
|
| Dividend Growth | 100.00% | 0% | 0% | 0% | 60.00% | 66.67% | Upgrade
|
| Gross Margin | 64.18% | 63.05% | 59.62% | 62.13% | 65.01% | 61.55% | Upgrade
|
| Operating Margin | 12.39% | 12.09% | 11.26% | 18.16% | 24.25% | 15.96% | Upgrade
|
| Profit Margin | 7.75% | 7.10% | 7.54% | 15.16% | 21.03% | 13.04% | Upgrade
|
| Free Cash Flow Margin | 10.52% | 6.93% | 4.98% | 6.47% | 13.44% | 5.68% | Upgrade
|
| EBITDA | 14,302 | 12,644 | 9,460 | 12,749 | 15,073 | 9,384 | Upgrade
|
| EBITDA Margin | 16.76% | 16.41% | 15.14% | 21.87% | 27.81% | 20.18% | Upgrade
|
| D&A For EBITDA | 3,724 | 3,328 | 2,427 | 2,158 | 1,927 | 1,963 | Upgrade
|
| EBIT | 10,578 | 9,316 | 7,034 | 10,591 | 13,146 | 7,421 | Upgrade
|
| EBIT Margin | 12.39% | 12.09% | 11.26% | 18.16% | 24.25% | 15.96% | Upgrade
|
| Effective Tax Rate | 33.14% | 37.48% | 34.60% | 20.17% | 17.39% | 18.32% | Upgrade
|
| Revenue as Reported | 86,217 | 78,298 | 63,699 | 58,964 | 54,828 | 47,157 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.